MedPath

E-Z-HD

These highlights do not include all the information needed to use E-Z-HD safely and effectively. See full prescribing information for E-Z-HD. E-Z-HD (barium sulfate) for oral suspension,Initial U.S. Approval: 2016

Approved
Approval ID

a4330804-7179-472a-91cb-84bbd5079bb8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 4, 2022

Manufacturers
FDA

E-Z-EM Canada Inc

DUNS: 204211163

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

barium sulfate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code32909-764
Application NumberNDA208036
Product Classification
M
Marketing Category
C73594
G
Generic Name
barium sulfate
Product Specifications
Route of AdministrationORAL
Effective DateMay 31, 2016
FDA Product Classification

INGREDIENTS (11)

ethyl maltolInactive
Code: L6Q8K29L05
Classification: IACT
Barium SulfateActive
Quantity: 980 mg in 1 g
Code: 25BB7EKE2E
Classification: ACTIB
acaciaInactive
Code: 5C5403N26O
Classification: IACT
anhydrous citric acidInactive
Code: XF417D3PSL
Classification: IACT
dimethicone 1000Inactive
Code: MCU2324216
Classification: IACT
polysorbate 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
saccharin sodiumInactive
Code: SB8ZUX40TY
Classification: IACT
silicon dioxideInactive
Code: ETJ7Z6XBU4
Classification: IACT
trisodium citrate dihydrateInactive
Code: B22547B95K
Classification: IACT
sorbitolInactive
Code: 506T60A25R
Classification: IACT
carrageenan sodiumInactive
Code: 7CY8BVL34N
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

E-Z-HD - FDA Drug Approval Details